Doxorubicin is used to treat many types of childhood cancer, but it can damage the heart. Giving dexrazoxane (Zinecard) before each dose greatly reduces a child's risk of treatment-related heart problems in adulthood.
Updated results from a large clinical trial confirm that, for some people with bladder cancer, receiving nivolumab (Opdivo) after surgery is an effective treatment.
Many cancers that respond to targeted therapy will become resistant to the drugs in time. Researchers have learned more about how this resistance happens and how it may be disrupted.
Information specialists at NCI's Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.
This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892
No comments:
Post a Comment